申请人:The Dow Chemical Company
公开号:US03933912A1
公开(公告)日:1976-01-20
Substituted phenylthioamidine compounds such as 2-(4-chlorophenylthio)acetamidine; 2-(4-chlorophenylthio)-acetamidoxime; and their pharmaceutically acceptable salts are prepared by the reaction of a substituted phenylthioacetonitrile with hydroxylamine hydrochloride or with methanol followed by ammonium chloride. The compounds have antimicrobial activity and also inhibit ADP-induced aggregation of blood platelets.
取代苯硫脲类化合物,如2-(4-氯苯硫基)乙酰胺啉;2-(4-氯苯硫基)-乙酰胺肟;及其药学上可接受的盐,可通过取代苯硫脲乙腈与盐酸羟胺或甲醇后接氯化铵反应制备而成。这些化合物具有抗微生物活性,并抑制ADP诱导的血小板聚集。